Back to Results
First PageMeta Content
Science / Medicine / Design of experiments / Pharmacology / Food and Drug Administration / Division of Acquired Immunodeficiency Syndrome / Data monitoring committees / Clinical trial / Safety monitoring / Clinical research / Research / Pharmaceutical industry


Policy: Study Progress and Safety Monitoring
Add to Reading List

Document Date: 2013-07-15 14:51:25


Open Document

File Size: 142,45 KB

Share Result on Facebook

Company

CVs / Immunodeficiency Syndrome / OPCRO Policy Group / monitoring by a DAIDS-appointed DSMB / /

Country

United States / /

Event

FDA Phase / /

Facility

National Institute of Allergy / /

IndustryTerm

clinical site / clinical research site / /

MedicalCondition

Acquired Immunodeficiency Syndrome / AIDS / /

Organization

DAIDS Office for Policy / Safety Monitoring Board / National Institute of Allergy and Infectious Diseases / National Institute of Health / Date Office for Policy / U.S. Food and Drug Administration / DAIDS PO / SPSMP / National Institute of Allergy / Infectious Diseases / DAIDS DSMB / Study Monitoring Committee / DAIDS V / Data and Safety Monitoring Board / /

Person

Richard Hafner / /

Position

Investigator / Director 20 DEC / Principal Investigator / Director / Program Officer / physician / chairperson / Officer / /

Product

E6 / SR-01 / /

Technology

html / /

URL

http /

SocialTag